TANYA MONAGHAN Tanya.Monaghan@nottingham.ac.uk
Clinical Associate Professor in Luminal Gastroenterology
Clostridioides difficile: innovations in target discovery and potential for therapeutic success
Monaghan, Tanya M.; Seekatz, Anna M.; Mullish, Benjamin H.; Moore-Gillon, Claudia E.R.; Dawson, Lisa; Ahmed, Ammar; Kao, Dina; Chan, Weng C.
Authors
Anna M. Seekatz
Benjamin H. Mullish
Claudia E.R. Moore-Gillon
Lisa Dawson
Ammar Ahmed
Dina Kao
Prof WENG CHAN WENG.CHAN@NOTTINGHAM.AC.UK
Professor of Chemical Biology
Abstract
Introduction: Clostridioides difficile infection (CDI) remains a worldwide clinical problem. Increased incidence of primary infection, occurrence of hypertoxigenic ribotypes, and more frequent occurrence of drug resistant, recurrent, and non-hospital CDI, emphasizes the urgent unmet need of discovering new therapeutic targets. Areas covered: We searched PubMed and Web of Science databases for articles identifying novel therapeutic targets or treatments for C. difficile from 2001 to 2021. We present an updated review on current preclinical efforts on designing inhibitory compounds against these drug targets and indicate how these could become the focus of future therapeutic approaches. We also evaluate the increasing exploitability of gut microbial-derived metabolites and host-derived therapeutics targeting VEGF-A, immune targets and pathways, ion transporters, and microRNAs as anti-C. difficile therapeutics, which have yet to reach clinical trials. Our review also highlights the therapeutic potential of re-purposing currently available agents. We conclude by considering translational hurdles and possible strategies to mitigate these problems. Expert opinion: Considerable progress has been made in the development of new anti-CDI drug candidates. Nevertheless, a greater comprehension of CDI pathogenesis and host-microbe interactions is beginning to uncover potential novel therapeutic targets, which can be exploited to plug gaps in the CDI drug discovery pipeline.
Citation
Monaghan, T. M., Seekatz, A. M., Mullish, B. H., Moore-Gillon, C. E., Dawson, L., Ahmed, A., …Chan, W. C. (2021). Clostridioides difficile: innovations in target discovery and potential for therapeutic success. Expert Opinion on Therapeutic Targets, 25(11), 949-963. https://doi.org/10.1080/14728222.2021.2008907
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 17, 2021 |
Online Publication Date | Dec 2, 2021 |
Publication Date | Dec 2, 2021 |
Deposit Date | Nov 19, 2021 |
Publicly Available Date | Dec 3, 2022 |
Journal | Expert Opinion on Therapeutic Targets |
Print ISSN | 1472-8222 |
Electronic ISSN | 1744-7631 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Volume | 25 |
Issue | 11 |
Pages | 949-963 |
DOI | https://doi.org/10.1080/14728222.2021.2008907 |
Keywords | Clinical Biochemistry; Drug Discovery; Pharmacology; Molecular Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/6737791 |
Publisher URL | https://www.tandfonline.com/doi/full/10.1080/14728222.2021.2008907 |
Files
Clostridioides difficile: innovations in target discovery and potential for therapeutic success
(2.5 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission
(2016)
Journal Article
Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection
(2016)
Journal Article
New perspectives in Clostridium difficile disease pathogenesis
(2015)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search